It can be very easy to be disheartened by the SP and what would appear to be a lack of support. With the current macro environment, a "mid cap speculative biotech stock" is going to be a hard sell for investors. Let's look at some positives.
1. 12 month purchase blackout for employees and the board.
2. Announcements from 12 months ago regarding the research of new molecules.
3. MOA is known.
4. Patent application lodged.
5. A trial is underway with at least one patient treated.
6.........................There's more to come.
What secrets are going to be revealed? There's def something coming.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.005(0.44%) |
Mkt cap ! $196.3M | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.12 | $202.7K | 178.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22685 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 12644 | 3 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |